ICAN®—International Cancer Advocacy Network

Marcia Horn Discusses Advancements in EGFR Exon 20 Insertion+ NSCLC and the Importance of Community - AJMC

"Patients with EGFR exon 20 insertion have a very promising drug pipeline in addition to 2 critically important drug approvals. Few rare mutation groups see this so early on... "
Read more

Fistbump Fundraiser Logo   Fistbump Fundraiser!

Donate to our major fundraiser honoring Exon 20 Group Founder Kevin Hanlon, supporting our research and advocacy projects! More info here: https://askican.ejoinme.org/fistbump